Compare International Business Machines Corp (IBM) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Nuwellis Inc — how do they compare? International Business Machines Corp trades at $225.93 (market cap $207.75B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: International Business Machines Corp is far larger — about 94431.8× Nuwellis Inc's market cap, and International Business Machines Corp pays a 3.07% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and Nuwellis Inc for 26 Days on average.
| IBM | NUWE | |
|---|---|---|
Market Cap | $207.75B | $2.20M |
Volume | 3,864,661 | 121,544 |
Sector | Technology | Health |
52-Week High | $329.23 | $146.65 |
52-Week Low | $205.77 | $0.68 |
Typical Hold Time | 88 Days | 26 Days |
Enterprise Value | $264.89B | -$1.52M |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM stock trades at $226.61, up 2.4% with recent momentum driven by positive sentiment in the consulting sector following Accenture's strong earnings. The company shows solid fundamentals with 2025 revenue growth to $67.54B and net income margin of 15.52%, though technical indicators remain bearish overall. Recent developments include the introduction of self-hosted deployment for IBM Bob AI platform and board expansion with Frank Baker's election.
IBM presents a mixed investment case with strong profitability metrics and analyst consensus target of $256.69 offering 13% upside, but faces headwinds from bearish technical signals and recent earnings miss. The company's pivot to high-margin hybrid cloud and AI consulting shows promise, though execution risks and competitive pressures in the AI space warrant caution.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
